 |
|
|
|
|
|
|
|
|
|
|
|
1 to 12 of 12 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Galasko D. on PAPER: Cullen VC. et al., 2012, This is an interesting paper. It revisits aspects of standardization of Innogenetics Aβ assays... 26 May 2012.
|
|
|
 |
|
|
Galasko D. on PAPER: Gandy S. et al., 2012, The editorial makes several important points. Perhaps the most important is that we need a much... 18 May 2012.
|
|
|
|
|
|
Galasko D. on NEWS: In Mice, Oxidative Changes Come Early and Antioxidants Work, These two studies cover different aspects of oxidative stress. The Brewer group showed that... 27 Apr 2012.
|
|
|
|
|
|
Galasko D. on PAPER: Ioannidis JP. et al., 2011, This JAMA paper subjects a number of blood-based tests, thought to have diagnostic... 3 Jun 2011.
|
|
|
|
|
|
Galasko D. on PAPER: Fagan AM. et al., 2011, This study is timely in comparing two widely used platforms (ELISA and bead-based multiplex... 18 May 2011.
|
|
|
|
|
|
Galasko D. on PAPER: Golde TE. et al., 2011, This is an excellently written and compelling review, which adds to the drumbeat of support for... 27 Jan 2011.
|
|
|
|
|
|
Galasko D. on PAPER: Kim HJ. et al., 2008, The remarkably high incidence of ALS among the Chamorros of Guam in the mid-1940s, and the... 4 Feb 2008.
|
|
|
|
|
|
Galasko D. on PAPER: Brayne C. et al., 2007, The JAMA commentary by Carol Brayne et al. carefully considers the issues surrounding routine... 21 Dec 2007.
|
|
|
|
|
|
Galasko D. on PAPER: Dickerson TJ. et al., 2003, I find these results interesting. Since I'm not an expert in Ab... 30 Jun 2003.
|
|
|
|
|
|
Galasko D. on PAPER: Egan MF. et al., 2003, Recommendation Only. 24 Feb 2003.
|
|
|
|
|
|
Galasko D. on PAPER: Skoog I. et al., 2003, The argument that A-beta alterations precede the onset of AD is reinforced by this interesting... 24 Feb 2003.
|
|
|
|
|
|
Galasko D. on NEWS: Diagnosing the Early Stages of Alzheimer's, The three papers examine the important issue of whether subtle changes in psychometric measures... 18 Apr 2002.
|
|
|
|
|
|
|
1 to 12 of 12 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
